Mrs Priyadarsini Gangadharannambiar

The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions (2024)
Wang, Yuzhuo; Scurll, Joshua; Rascón, Itzel Astiazarán; Cui, Cassandra; Ni, Yuchao; Shi, Ace Mingchen; Gangadharannambiar, Priyadarsini; Wang, Yu; Akamatsu, Shusuke; Beltran, Himisha; Cox, Michael; Crea, Francesco; Daugaard, Mads; Dong, Xuesen; Haffner, Michael; He, Hansen; Jachetti, Elena; Kyprianou, Natasha; Li, Benyi; Ong, Christopher E; Rickman, David S; Sen, Triparna; Zhu, Helen He; Zoubeidi, Amina and Gleave, Martin E
Epigenomics ((Early access))

Calcium signalling pathways in prostate cancer initiation and progression (2023-09)
Silvestri, Roberto; Nicolì, Vanessa; Gangadharannambiar, Priyadarsini; Crea, Francesco and Bootman, Martin D.
Nature reviews. Urology, 20 (pp. 524-543)

Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib (2022-05)
Salani, Francesca; Latarani, Maryam; Casadei-Gardini, Andrea; Gangadharannambiar, Priyadarsini; Fornaro, Lorenzo; Vivaldi, Caterina; Pecora, Irene; Massa, Valentina; Marisi, Giorgia; Canale, Matteo; Ulivi, Paola; Scartozzi, Mario; Eccleston, Mark; Masi, Gianluca and Crea, Francesco
Epigenomics, 14(9) (pp. 507-517)

Discovery of candidate hub genes in breast cancer (2019)
Chandler, Stephen; Gangadharannambiar, Priyadarsini; Crea, Francesco; Hirst, Mark; Cox, Angela and Rigas, Sushila
In : New Developments in Breast Cancer Research - From the Lab to the Clinic, 2019 BACR Special Conference (9-11 Oct 2019, The Sage, Newcastle Gateshead, UK)

Discovery of candidate long non-coding RNAs as biomarkers and treatment targets for prostate cancer (2019)
Chandler, Stephen; Gangadharannambiar, Priyadarsini; Crea, Francesco; Hirst, Mark; Cox, Angela and Rigas, Sushila
In : NEPC 2019. Treatment-emergent neuroendocrine prostate cancer: clinical relevance and molecular pathogenesis. (25 Jun 2019, The Open University, Milton Keynes, UK)